P3.01-52 the Role of Serum Carcinoembryonic Antigen to Predict the Response of Treatment in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology- United States

doi 10.1016/j.jtho.2018.08.1612

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P3.01-40 Treatment of Super Elderly Patients for Non-Small Cell Lung Cancer in Japan

Journal of Thoracic Oncology

Respiratory Medicine

English

Circulating Nucleosomes Predict the Response to Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research

Cancer Research

English

P3.01-67 Integrated Network Analysis to Understand the Potential Mechanisms of Hydroxychlrorquine in Non-Small Cell Lung Cancer Treatment

Journal of Thoracic Oncology

Respiratory Medicine

English

Decreased Levels of Serum Cytokeratin 19 Fragment CYFRA 21-1 Predict Objective Response to Chemotherapy in Patients With Non-Small Cell Lung Cancer

Experimental and Therapeutic Medicine

Cancer Research

English

P3.01-82 Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-36 Prognostic Factors in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

sLAG-3 in Non-Small-Cell Lung Cancer Patients’ Serum

OncoTargets and Therapy

German

P3.01-086 Biomarker Testing Trends and Treatment Patterns in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients in the United States

Journal of Thoracic Oncology

Respiratory Medicine

English

Update on the Role of Topotecan in the Treatment of Non-Small Cell Lung Cancer

Cancer Research

English